ÍøºìºÚÁÏ

Skip to main content
(352) 273-8740

Ali Ataya, MD : Research

Critical Care Medicine Specialist, Pulmonologist (Lung Specialist)

Photo of Ali Ataya
(352) 273-8740 MyUFÍøºìºÚÁÏ

Research at a glance

Top areas of exploration

  • Dyspnea , 10 publications
  • Pulmonary Alveolar Proteinosis , 4 publications
  • Lymphangioleiomyomatosis , 4 publications
  • Fever , 4 publications

Research activity

122 publications

396 citations

Why is this important?

Active clinical trials

United therapeutics 301

Study ROR-PH-301, ADVANCE OUTCOMES, is designed to assess the efficacy and safety of ralinepag when added to pulmonary arterial hypertension (PAH) standard of care or PAH-specific background therapy in subjects with World ÍøºìºÚÁÏ Organization (WHO)…

Investigator
Ali Ataya
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All
Sapphire

This study aims to evaluate the efficacy and safety of inhaled treprostinil in subjects with sarcoidosis-associated interstitial lung disease and pulmonary hypertension.

Investigator
Ali Ataya
Status
Accepting Candidates
Ages
18 Years - 99 Years
Sexes
All

My publications

122 publications

2024

A 35-Year-Old Woman With Placenta Previa and Postpartum Cardiovascular Collapse

CHEST

2024

A perfectly imperfect engine: Utilizing the digital twin paradigm in pulmonary hypertension

Pulmonary Circulation

2024

Abdominal pain in a patient with epistaxis, telangiectasias, and arteriovenous malformations.

Cleveland Clinic journal of medicine

•

2024

Autoimmune Pulmonary Alveolar Proteinosis: A Review of Pathogenesis and Emerging Therapies

Current Pulmonology Reports

2024

Comment on the European Respiratory Society pulmonary alveolar proteinosis guidelines.

The European respiratory journal

•